Clinical Trials Browser

Smoldering Multiple Myeloma, Lymphoma, Waldenstrom Macroglobulinemia, Multiple Myeloma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

NCT06212323 2026-02-17

SPOTLIGHT

Recruiting

100 enrolled

Plasma cell

Smoldering Multiple Myeloma

NCT02269592 2026-02-12

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Recruiting

10,000 enrolled

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT06644625 2026-01-20

CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study

Recruiting

1,665 enrolled

Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT06237803 2025-12-03

EMN36

Recruiting

6,000 enrolled

Other hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Leukemia, Plasma Cell, Multiple Myeloma

NCT03717844 2025-11-20

Registry for Adults With Plasma Cell Disorders (PCD's)

Recruiting

2,000 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Amyloidosis, Cryoglobulinemia, Castleman Disease, Leukemia, Plasma Cell, Multiple Myeloma, POEMS Syndrome

NCT07214324 2025-11-19

PNRR-2022-1237

Active not recruiting

60 enrolled

Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT03616483 2025-11-10

The Indiana Myeloma Registry

Recruiting

2,500 enrolled

Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Paraproteinemias, Plasmacytoma

NCT03951220 2025-08-19

LOOMIS

Completed

67 enrolled 24 charts

Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Neoplasms, Plasma Cell

NCT06365060 2025-08-06

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

Recruiting

400 enrolled

Plasma cell

Smoldering Multiple Myeloma, Immunoglobulin Light-chain Amyloidosis

NCT06895291 2025-03-30

ONCO-MRI

Recruiting

1,000 enrolled

LymphoidPlasma cell

Smoldering Multiple Myeloma, Lymphoma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT04023747 2025-02-03

OxPLoreD

Active not recruiting

574 enrolled

LymphoidPlasma cell

Smoldering Multiple Myeloma, Lymphoproliferative Disorders

NCT04615572 2024-10-28

Screening to Improve Survival in AL Amyloidosis

Completed

35 enrolled

Plasma cell

Smoldering Multiple Myeloma, Immunoglobulin Light-chain Amyloidosis, Monoclonal Gammopathy of Undetermined Significance

NCT02298816 2024-10-03

HMvax-Regist

Withdrawn

LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Influenza, Human, Lymphocytosis, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Pneumonia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Hematologic Neoplasms

NCT05283993 2022-04-25

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Recruiting

2,000 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Amyloidosis, Cryoglobulinemia, Castleman Disease, Leukemia, Plasma Cell, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, POEMS Syndrome

NCT05047107 2021-09-16

COSMOS

Unknown

500 enrolled

Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

NCT04727294 2021-08-04

MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey

Unknown

1,500 enrolled

Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Coronavirus Infections

NCT01079429 2021-04-15

GENOMGUS

Terminated

1,200 enrolled

Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

NCT01109407 2021-03-08

Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)

Terminated

225 enrolled

Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Neoplasms, Plasma Cell

NCT00919139 2015-04-03

S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.

Completed

190 enrolled

LymphoidPlasma cell

Smoldering Multiple Myeloma, Immunoglobulin Light-chain Amyloidosis, Amyloidosis, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

Clinical Trials

Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma

ProDigALIty

Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies

A Real-world Study in Participants With Smoldering Multiple Myeloma

TRANSFORMM

Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders

SPOTLIGHT

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study

EMN36

Registry for Adults With Plasma Cell Disorders (PCD's)

PNRR-2022-1237

The Indiana Myeloma Registry

LOOMIS

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

ONCO-MRI

OxPLoreD

Screening to Improve Survival in AL Amyloidosis

HMvax-Regist

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

COSMOS

MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey

GENOMGUS

Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)

S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.